|
COMPANY NEWS Recently, the Shanghai Municipal Commission of Economy and Informatization published the list of Shanghai Innovative Small and Medium-Sized enterprises in 2023 (the fourth releasing), where our compan
2024-03-22
Recently, the Shanghai Municipal Commission of Economy and Informatization published the list of Shanghai Innovative Small and Medium-Sized enterprises in 2023 (the fourth releasing), where our compan
2024-03-22
Currently, the 15-Valent Recombinant Human Papillomavirus Vaccine (Hansenula polymorpha), jointly developed by Shanghai Bovax Biotechnology Co., Ltd. and its subsidiary company Chongqing Bo...
2024-02-01
Since November, a new round of the Covid-19 epidemic had been spreading in Chongqing. In response, Chongqing Bovax has implemented closed-loop management. Before conducting closed-loop management, ...
2022-12-08
Currently, Bovax has initiated the Phase I clinical trial for the Recombinant Enterovirus 71 Vaccine (Hansenula polymorpha), which developed independently by Bovax. The first subject has be...
2022-10-25
Prev
1
Next
|
